Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Biovail Corp (USA) (NYSE:BVF.DL)

CAPS Rating: No stars

A specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. Its main therapeutic areas are central nervous system disorders, pain management and cardiovascular disease.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:BVF.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Grinnell4Eva (< 20)
Submitted May 30, 2008

Wellbutrin generics should continue to come under pressure from their poor efficacy vis-a-vis the brand name product. Huge buybacks on the horizon. Refocused management has put past scandals behind them and looks to pour cash into R & D pipeline… More

Civildriver (< 20)
Submitted January 03, 2008

BVF stock is a big money losser.

NYSE:BVF.DL VS S&P 500 (SPY)

NYSE:BVF.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about BVF.DL.

No one has written a Pitch for BVF.DL stock yet. Tell us why you think BVF.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in BVF.DL.

No players have picked BVF.DL yet. Tell us why you think BVF.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BVF.DL.